InvestorsHub Logo
icon url

James salmon

06/19/19 8:38 AM

#99989 RE: ubmmg #99988

Personally I think its important we get FDA nod for early data of AXAL, I think this is holding a lot up at the moment in relation to any deal or IST’s that are being worked on.
icon url

raja48185

06/19/19 9:20 AM

#99991 RE: ubmmg #99988

From WSJ:
“MRK is searching for small and midsize deals, including more transactions aimed at expanding its portfolio of cancer treatments beyond Keytruda.”

So, question is: Does Merck consider Advaxis as a target for a deal?


Not sure. But long time investors are going to lose money even if MRK decides to buy ADXS.
icon url

oakrock

06/20/19 4:53 AM

#100014 RE: ubmmg #99988

Let's put it this way, for them the cost is chump change.